[1] 常艳美,林新祝,张蓉,等. 早产儿代谢性骨病临床管理专家共识(2021)[J].中国当代儿科杂志,2021,23(8):761-772. [2] 金宏娟, 谢丽清, 吴小颖, 等. 血清25羟基维生素D与早产儿代谢性骨病的相关性[J].中国小儿急救医学,2020, 27(5):388-391. [3] Chinoy A,Mughal MZ,Padidela R. Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(5):F560-F566. [4] Figueras-Aloy J, Alvarez-Dominguez E, Perez-Fernandez JM, et al. Metabolic bone disease and bone mineral density in very preterm infants[J]. J Pediatr, 2014, 164(3):499-504. [5] Abdallah EAA, Said RN, Mosallam DS, et al. Serial serum alkaline phosphatase as an early biomarker for osteopenia of prematurity[J]. Medicine(Baltimore), 2016, 95(37):e4837. [6] Backstrom MC, Kouri T, Kuusela AL, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity[J]. Acta Paediatr, 2000, 89(7):867-873. [7] 马晓路, 罗芳, 施丽萍, 等. 早产儿代谢性骨病4例[J]. 中国循证儿科杂志, 2009, 4(2):156-158. [8] Jensen EA,White AM,Liu P,et al. Determinants of severe metabolic bone disease in very low-birth-weight infants with severe bronchopulmonary dysplasia admitted to a tertiary referral center[J]. Am J Perinatol, 2016, 33(1):107-113. [9] 吴明祥, 马捷, 凌人男, 等. 早产儿代谢性骨病4例及文献复习[J]. 临床放射学杂志, 2014, 33(12):1945-1947. [10] 贺晓日,梁灿,俞元强,等. 极低/超低出生体重早产儿代谢性骨病危险因素的全国多中心调查[J].中国当代儿科杂志,2021,23(6):555-562. [11] Binder C,Wild J,Thanhaeuser M,et al. Osteopenic fractures in preterm infants <1,500 grams-A retrospective data analysis over 10 years at the Medical University of Vienna[J]. Pediatrics,2015,17(2):468-476. [12] 李崇,富建华. 早产儿代谢性骨病诊治的研究进展[J].中国小儿急救医学,2021,28(1):50-54. [13] Mutlu M, Akturk-Acar F, Kader S, et al. Risk factors and clinical characteristics of metabolic bone disease of prematurity[J]. Am J Perinatol, 2021,11(5):519-524. [14] Abrams SA,Committee on Nutrition. Calcium and vitamin D requirements of enterally fed preterm infants[J]. Pediatrics, 2013, 131(5):e1676-e1683. [15] Ukarapong S, Venkatarayappa SKB, Navarrete C,et al. Risk factors of metabolic bone disease of prematurity[J]. Early Hum Dev, 2017,112:29-34. [16] Hoppe B, Duran I, Martin A, et al. Nephrocalcinosis in preterm infants: a single center experience[J]. Pediatr Nephrol, 2002, 17(4):264-268. [17] Viswanathan S, Khasawneh W, Mcnelis K, et al. Metabolic bone disease: a continued challenge in extremely low birth weight infants[J]. JPEN,2014, 38(8):982-990. [18] Rehman MU, Narchi H. Metabolic bone disease in the preterm infant: current state and future directions[J]. World J Methodol, 2015, 5(3):115-211. [19] Chacham S, Pasi R, Chegondi M, et al. Metabolic bone disease in premature neonates-an unmet challenge[J].Clin Res Pediatr Endocrinol,2020,12(4):332-339. [20] Zhang WW, Yu YH, Dong XY, et al. Treatment status of extremely premature infants with gestational age <28 weeks in a Chinese perinatal center from 2010 to 2019[J]. World J Pediatr,2022, 18(1):67-74. [21] 王玮,牛彦鹏. 西安市早产儿代谢性骨病患病影响因素的病例对照研究[J].实用预防医学,2020,26(3):362-365. [22] Brunetti G, Faienza MF, Piacente L, et al. High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment[J]. Am J Physiol Endocrinol Metab, 2013, 304(5):546-554.
2024, Vol. 31 
